Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

April 30, 2016

Conditions
PainPeripheral Neuropathy
Interventions
DRUG

pregabalin

Given PO

DRUG

placebo

Given PO

OTHER

questionnaire administration

Ancillary studies

Trial Locations (6)

54449

Marshfield Clinic - Marshfield Center, Marshfield

55805

Essentia Health-Duluth CCOP, Duluth

55905

Mayo Clinic, Rochester

56303

Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud

67214

Cancer Center of Kansas, Wichita

68106

Missouri Valley Cancer Consortium, Omaha

All Listed Sponsors
lead

Academic and Community Cancer Research United

OTHER

NCT01637077 - Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel | Biotech Hunter | Biotech Hunter